New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
August 13, 2013
08:46 EDTOWW, DGIT, APP, MRK, AVNR, NQ, SINA, LLY, YUM, XRX, JCPOn The Fly: Pre-market Movers
UP AFTER EARNINGS: NQ Mobile (NQ), up 10%... Sina (SINA), up 6.5%. ALSO HIGHER: Digital Generation (DGIT), up 38% after selling television ad delivery business for $485M, announcing plan to form new company that will hold DG's online business... Avanir Pharmaceuticals (AVNR), up 9% after announcing an agreement to co-promote Merck (MRK) therapies in U.S. long-term care institutions... Eli Lilly (LLY), up 4.3% after lung cancer drug met endpoint in trial... Xerox (XRX), up 3% following upgrade to Buy from Neutral at Citigroup... J.C. Penney (JCP), up 1.4% after Bill Ackman resigns from board. DOWN AFTER EARNINGS: American Apparel (APP), down 4.5%. ALSO LOWER: Yum! Brands (YUM), down 3.2% after announcing July same-store sales in its China division fell 13%, including a 16% drop at KFC stores... Orbitz Worldwide (OWW), down 12% after announcing PAR Capital Management has sold 8.1M of its 24.6M shares of Orbitz Worldwide stock.
News For JCP;XRX;YUM;LLY;SINA;NQ;AVNR;MRK;APP;DGIT;OWW From The Last 14 Days
Check below for free stories on JCP;XRX;YUM;LLY;SINA;NQ;AVNR;MRK;APP;DGIT;OWW the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | 5 | all recent news | >>
July 17, 2014
09:43 EDTYUMYum! Brands sees FY14 EPS growth of 20%, consnesus $3.73
The company expects to sustain double digit EPS growth in 2015 and beyond
09:36 EDTYUMYum! Brands Taco Bell breakfast option off to a 'great start'
Subscribe for More Information
09:15 EDTYUM, OWWOn The Fly: Pre-market Movers
HIGHER: Dresser-Rand (DRC), up 15.5% after Manager Magazin says Siemens (SIEGY) preparing bid for the company. Other oil equipment companies with a market cap similar to Dresser-Rand's include Dril-Quip (DRQ) and Oil States (OIS)... Microsoft (MSFT), up 3.4% after announcing restructuring, including plans to cut up to 18K jobs. UP AFTER EARNINGS: Morgan Stanley (MS) up 1.5%... Sherwin-Williams (SHW), up 3%. DOWN AFTER EARNINGS: Mattel (MAT), down 7.3%... Sandisk (SNDK), down 7%... Yum! Brands (YUM), down 2.5%. LOWER: Orbitz (OWW), down 3% after results, 34M share spot secondary offering of stock priced at $8.25... Benefitfocus (BNFT), down 1% after 2.5M share Secondary priced at $38.50.
09:12 EDTOWWUpdate: Orbitz 34M share Spot Secondary priced at $8.25
Subscribe for More Information
09:06 EDTOWWOrbitz 20M share Spot Secondary priced at $8.25
Subscribe for More Information
07:15 EDTYUMYum! Brands shares should be bought after mixed Q2 results, says Stifel
Subscribe for More Information
06:47 EDTAPPStandard General plans American Apparel future without ex-CEO, Reuters says
Subscribe for More Information
July 16, 2014
18:26 EDTYUM, OWWOn The Fly: After Hours Movers
Subscribe for More Information
17:06 EDTYUMYum! Brands down 2.5% after reporting Q2 results below analyst estimates
17:03 EDTYUMYum! Brands falls after results, levels to watch
The shares are down 2.4% in the extended session following earnings. At the current price of $80.69 the stock has slipped below support at the 30-day moving average. Next support below is at the 50-day moving average, last at $78.71. Resistance is at $81.20.
16:15 EDTOWWOrbitz drops 4% to $8.60 after announcing 20M share secondary
Subscribe for More Information
16:12 EDTYUMYum! Brands reports Q2 EPS 73c, consensus 74c
Subscribe for More Information
16:06 EDTOWWOrbitz sees Q2 revenue $248M, consensus $242.99M
Sees Q2 stayed room night growth up 20% year-over-year and adjusted EBITDA $45M.
16:02 EDTOWWOrbitz files to sell 20M shares of common stock
Credit Suisse Securities is serving as the lead book-running manager.
15:28 EDTYUMYum! Brands (YUM) July 82 straddle priced for 3.8% move into Q2
11:58 EDTXRXDruckenmiller says IBM facing problems similar to Xerox, Kodak
Subscribe for More Information
09:13 EDTAVNRAvanir's Nuedexta shows positive early results in clinical study of Alzheimer's
Subscribe for More Information
08:21 EDTLLYEli Lilly reports beta-amyloid imaging results in Alzheimer's Disease
Subscribe for More Information
07:05 EDTLLYEli Lilly and Immunocore partner to develop cancel therapies
Eli Lilly and Immunocore today announced they have entered into a co-discovery and co-development collaboration to research and potentially develop novel T cell-based cancer therapies. Immunocore will receive an upfront fee of $15M per program for the discovery of novel ImmTACs against jointly-selected cancer targets in order to generate preclinical candidate packages. If Lilly accepts a preclinical candidate package to develop and potentially commercialize, Immunocore will receive an opt-in fee of $10M and will have an option to continue co-development with Lilly on a cost-sharing and profit-sharing basis. If Immunocore does not exercise its option, it will be entitled to potential future significant milestone and royalty payments.
06:26 EDTMRKBristol-Myers lung cancer trials being underestimated, says Citigroup
After building a statistical model of Bristol-Myers' two critical registration trials for Opdivo in lung cancer, Citigroup believes the market is "materially" underestimating both Phase III trials. Citi says potential Opdivo FDA approval in 2015 in lung cancer would give Bristol-Myers an up to two year lead time versus Merck (MRK) and Roche (RHHBY). The firm estimates 2023 Opdivo revenue at $7B and reiterates a Buy rating on Bristol with a $60 price target.
1 | 2 | 3 | 4 | 5 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use